Allele Loss in Colorectal Cancer
Author Information
Author(s): IPM Tomlinson, M Ilyas, WF Bodmer
Primary Institution: Imperial Cancer Research Fund
Hypothesis
Is allele loss at the hMSH2 and hMLHI loci important in the pathogenesis of RER+ sporadic colorectal cancers?
Conclusion
Allele loss at hMLHI contributes to the RER+ status of a significant proportion of sporadic colorectal cancers, while loss at hMSH2 is rare.
Supporting Evidence
- 41% of RER+ tumours showed allele loss at hMLHI.
- 15% of RER- cancers showed allele loss at hMLHI.
- 9% of RER+ sporadic cancers had lost an allele at hMSH2.
- 5% of RER- cancers had lost an allele at hMSH2.
Takeaway
This study looked at how often certain genes are missing in colon cancer. They found that one gene is often missing in cancers with a specific problem, but another gene is usually not.
Methodology
The study analyzed allele loss at hMSH2 and hMLHI loci in sporadic colorectal cancers characterized as RER+ and RER-.
Limitations
Tumours were not microdissected from normal tissue, which may understate the true frequency of LOH.
Participant Demographics
Sporadic colorectal cancer cases from St Mark's Hospital, Harrow, UK.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website